Patients who, perhaps unbeknownst to their health care providers, are in need of genetic testing for rare undiagnosed diseases can be identified en masse based on routine information in electronic health records (EHRs), a research team reported June 3 in the journal Nature Medicine.

A 9-year-old patient of Monroe Carell Jr. Children’s Hospital at Vanderbilt is the first in the world to receive an investigational gene editing therapy for Methylmalonic Acidemia (MMA), a rare genetic disorder diagnosed at birth.

In her 2021 State of Nursing address, Executive Chief Nursing Officer Marilyn Dubree, MSN, RN, NE-BC, looked back on an unprecedented year of nursing care at Vanderbilt University Medical Center, responding to the COVID-19 pandemic as the organization continued to grow.

Petyon Smith's answered prayers became the best birthday wish ever on Jan. 31 — the date his younger brother received the first-ever dual kidney-liver transplant at Monroe Carell Jr. Children's Hospital at Vanderbilt.

According to an innovative large-scale clinical trial reported last week in the New England Journal of Medicine, a single daily baby aspirin (81 mg) or a single daily adult aspirin (325 mg) are equally safe and effective for prevention of adverse cardiovascular events for patients with established atherosclerotic cardiovascular disease.

On April 7, 2017, a devastating car crash sent Owen Canavan to Vanderbilt University Medical Center’s Trauma Intensive Care Unit, and he credits the medical team for saving his life.

The flexibility and adaptability of Vanderbilt University Medical Center has been center stage as the pressures of COVID-19 and ongoing strategic imperatives have transformed how and where care is delivered.